Tuesday, October 31, 2017 10:15 PM ET
Insider Selling at AbbVie (ABBV) Continues with Significant Sale
A SEC filing today revealed a notable insider sale of AbbVie shares as — Henry O Gosebruch, Officer — sold 18,300 shares in the company having a market value of approximately $1,657,037. There have been 3 insiders with buy/sell transactions in the past 90 days prior to this filing. These trades have resulted in the acquisition of 4,000 company shares and the disposition of 24,999 company shares over this time period. Adding the most recent activity to this 90-day history indicates insider trades have been net sales of 39,299 shares and have averaged 11,825 shares per transaction over this time period.
Over the last 90 days, the number of insider buy/sell trades at AbbVie is above its 19-company peer group average. The Specialty & Advanced Pharmaceuticals peer group saw 25 buy/sell trades during this period for an average of 1.3 transactions per company. However, the number of shares traded per transaction by AbbVie insiders is lower than its peers. Within the peer group there were 621,842 shares purchased and 237,563 shares sold with company insiders purchasing 20,225 shares on average over this time period.
To bring into focus significant insider buying and selling activity, all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers has been eliminated in data obtained to compose and write this story.
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at firstname.lastname@example.org. Copyright 2017 UpTick Data Technologies. All rights reserved.